Outsourcing in Clinical Trials New England 2021
Watch selected sessions from this year's Outsourcing in Clinical Trials New England conference here.
Arena International were delighted to host Outsourcing in Clinical Trials New England in Boston on the 9th-10th November 2021!
A range of in-person attendees joined leading experts from established institutes and smaller biotechs and dive into the operational challenges and innovations in clinical development found within the New England area. Over the 2 day event, over 200 delegates took the opportunity to network and discuss the common challenges and trends impacting the region such as COVID, steps for defining contractual relationships and getting the maximum from external providers, incentivising good relationships with CROs and constructing defined deadlines.
The 2021 event featured a keynote talk from Ken Getz, Associate Professor at Tufts University School of Medicine - not to be missed. Other talks from companies such as Novartis, Sanofi, Pfizer and AstraZeneca amongst others can be found in the on-demand link.
It is becoming clear that the only options are to disrupt or be disrupted: and so, this event focused on examining real world evidence into innovations and industry trends that you cannot afford to miss.
Looking forward to seeing you at the next one!
The 9th Outsourcing in Clinical Trials New England is the regional hub for the life sciences industry – with insightful learning opportunities and engaging networking on offer, this is the must attend event for clinical supply specialists to achieve excellence.
– Inspire – learn from thought leaders and take away valuable insight
– Network – connect with old faces and forge new relationships
– Discover – explore potential partners and solutions to help you meet your goals
‘That was a superb day, it feels like we’ve been at a real, in person, conference!’ Worldwide Clinical Trials
‘A great event, I met more people than I do at an in-person event and I’ve got loads of
follow ups’ Conversis
‘The whole setting is actually very well accomplished! Thanks again for the invitation!’ Apogenix AG
MedPoint Digital develops intuitive, ICH-GCP compliant eClinical platforms for virtual investigator meetings, trial portals, interactive modules, and virtual clinical trials. Our digital solutions enable sites to be more productive, with online study training, study eBinders (eISF), digital study alerts and SUSARs, patient visit guides, and a wide range of study tools, available via web portals and mobile apps.
As a global leader in business services for over 20 years, TransPerfect is a woman-owned, privately held company with over 90 offices globally on six continents. Since its inception, TransPerfect has been supporting life sciences in the conduct of global clinical development, commercialization and life cycle management of products catering to the health care community.
Advanced Clinical is a global clinical research services organization, providing CRO, FSP, Strategic Resourcing and Consulting Services for biopharmaceutical and medical device organizations. Our company is committed to improving all lives touched by clinical research and we address the hopes of patients and healthcare professionals with industry-leading services and technology in life sciences. Visit our website to learn more about how we deliver a Better Clinical Experience.
Founded in 1989, Biotrial is a leading CRO specialized in Early Development with a wide range of services from Non-Clinical Pharmacology, Phase I studies, Phase II-IV Trial Management, Bioanalysis, Oncology, Data Management, Biostatistics, ECG & Imaging Core Lab (QT/QTc Trials, Psychometric Testing, Imaging, EEG/PSG Assessment), Regulatory Affairs to Medical Writing.
CROMSOURCE is an international contract research organization providing a comprehensive services to the pharmaceutical and biotechnology companies. Specializing in clinical development and staffing solutions, we offer a flexible approach to ensure our clients’ unique needs are supported. CROMSOURCE is unparalleled in offering an end-to-end guarantee covering trial timelines, enrollment, and price. CROMSOURCE operates offices across Europe and North America.
Pharm-Olam International delivers cost effective, quality clinical services to pharma and biotech sponsors across all therapeutic areas in more than 40 countries. Since 1994, we have been committed to our objective: to create value for our clients by satisfying their clinical development needs with consistent and dependable solutions and services.
Philips BioTel Research is an industry leader in medical imaging and cardiovascular safety testing for clinical trials.
Philips BioTel Research offers global operational support for cardiovascular monitoring in all therapeutic areas, and advances imaging services in oncology, cardiovascular, metabolic, musculoskeletal, neurologic, and medical device studies. Their experienced research team comprises key opinion leaders, board-certified cardiologists and radiologists, sub-specialty scientists, and highly trained technicians – who acquire, evaluate, and report high-quality data through an efficient, cloud-based infrastructure. Many biopharmaceutical trial sponsors rely on or scientific leaders to help design and optimize their protocols and statistical analysis plans. We have conducted clinical trials contributing to the market approval of nearly 100 new drugs to date.
Red Nucleus Clinical Research combines the digital experience with health outcomes research bringing all R&D functions together in one place, by creating a mobile platform for both clinical and decentralized, evidence-based research and learning programs. The iTakeControl, fully integrated video capture platform, is purposefully designed to capture critical endpoints in a clinical, and remote or at home setting, with the added video de-identification suite to enable regulatory submissions and review. Our comprehensive platform customizes a mobile health solution for Real World Disease Management, Decentralized Clinical Trial Management, and R&D Management.
ObvioHealth is a Virtual Research Organization (VRO) pioneering decentralized clinical research. We launched in 2017, leveraging tech innovation to tackle the inefficiencies in the clinical trial process by designing one of the first patient centric mobile apps and platform, making it possible for people to participate in trials from their homes.
Our technology and team of experienced clinical scientists, clinical operations experts, and visionary health technologists make clinical trials safer, easier, faster, and deliver better data. ObvioHealth is on a constant quest to improve our platform and the clinical trial experience to bring more life-improving innovations to market.
Linical is a public, mid-sized Contract Research Organization headquartered in Japan with a significant presence across North America, Europe, and Asia-Pacific. Linical provides the full spectrum of drug development services from early stage to large-scale, multinational studies. Our areas of focus include Phase I-IV studies in oncology, infectious disease, and CNS. Rather than be all things to the market, this intentional design allows us to provide our clients the right size, right reach, and right team.
At Linical, we are the trusted, global CRO to deliver innovative solutions for even the most complex industry challenges. We provide our clients with the personal attention, flexibility, and reach needed for a continually evolving pharmaceutical and biotech market. We believe in supporting clients throughout their unique clinical development journey, with a shared goal of bringing promising new therapies to patients all over the world.
Linical’s vision is to be the CRO of choice amongst the global, mid-sized CRO market. We will achieve this by continuing to expand our current geographical reach into additional parts of the world, enabling us to thoughtfully partner with our clients anywhere their clinical development endeavors take them. While strategically growing our business, we are committed to maintaining the personal, attentive service our clients, employees, and patients deserve.
Schulman IRB and Chesapeake IRB have merged to create Advarra, the premier provider of IRB, IBC and global research compliance services. By integrating our innovative technology and proven regulatory expertise, Advarra helps ensure the highest standards of human research protections. Advarra supports all research phases across all major therapeutic areas.